Reporter gene imaging "visualized" the integration of two growing technologies: CRISPR/Cas9-based genome editing and induced pluripotent stem cell therapy

被引：0
|
作者：
Chiti, Arturo [1 ,2 ]
机构：
[1] IRCCS, Humanitas Clin & Res Ctr, Via Manzoni 56, I-20089 Rozzano, Mi, Italy
[2] Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini 4, I-20090 Milan, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / 03期
关键词：
TRANSPLANTATION;
D O I：
10.1007/s00259-020-05117-x
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：664 / 665
页数：2
相关论文
共 50 条
  • [1] Reporter gene imaging “visualized” the integration of two growing technologies: CRISPR/Cas9-based genome editing and induced pluripotent stem cell therapy
    Arturo Chiti
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 664 - 665
  • [2] Automated CRISPR/Cas9-based genome editing of human pluripotent stem cells using the StemCellFactory
    Niessing, Bastian
    Breitkreuz, Yannik
    Elanzew, Andreas
    de Toledo, Marcelo A. S.
    Vajs, Peter
    Nolden, Marina
    Erkens, Frederik
    Wanek, Paul
    Yeung, Si Wah Christina Au
    Haupt, Simone
    Koenig, Niels
    Peitz, Michael
    Schmitt, Robert H.
    Zenke, Martin
    Bruestle, Oliver
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2024, 12
  • [3] CRISPR/Cas9-based gene editing for Rett syndrome therapy
    Croci, S.
    Beligni, G.
    Rossetti, A.
    Edo, A.
    Sorg, T.
    Manara, M.
    Lo Rizzo, C.
    Mencarelli, M. A.
    Canitano, R.
    Sica, M.
    Capitani, K.
    Conticello, S. G.
    Molinaro, F.
    Chiariello, M.
    Chillon, M.
    Ladewig, J.
    Herault, Y.
    Renieri, A.
    Meloni, I.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A141 - A141
  • [4] Exploration of CRISPR/Cas9-based gene editing as therapy for osteoarthritis
    Zhao, Lan
    Huang, Jian
    Fan, Yunshan
    Li, Jun
    You, Tianming
    He, Shisheng
    Xiao, Guozhi
    Chen, Di
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (05) : 676 - 682
  • [5] Enhancing the therapeutic potential of mesenchymal stem cell-based therapy via CRISPR/Cas9-based genome editing
    Lee, K.
    Lee, N.
    Shin, E.
    Lee, N.
    Chang, J.
    Na, D.
    Lee, J.
    CYTOTHERAPY, 2020, 22 (05) : S15 - S15
  • [6] Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
    Ben Jehuda, Ronen
    Shemer, Yuval
    Binah, Ofer
    STEM CELL REVIEWS AND REPORTS, 2018, 14 (03) : 323 - 336
  • [7] Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
    Ronen Ben Jehuda
    Yuval Shemer
    Ofer Binah
    Stem Cell Reviews and Reports, 2018, 14 : 323 - 336
  • [8] Generation of two ISL1-tdTomato reporter human induced pluripotent stem cell lines using CRISPR-Cas9 genome editing
    Tsukamoto, Satomi
    Nakade, Koji
    Wakabayashi, Tamami
    Nakashima, Kenichi
    Takami, Miho
    Hemmi, Yasuko
    Kuramochi, Yuji
    Shimizu, Tomoya
    Arai, Yutaka
    Matsuo-Takasaki, Mami
    Noguchi, Michiya
    Nakamura, Yukio
    Miwa, Yoshihiro
    Hayashi, Yohei
    STEM CELL RESEARCH, 2021, 53
  • [9] CRISPR/CAS9-BASED GENE EDITING SOLUTION TO BOOST HEMOCOMPATIBILITY OF MESENCHYMAL STROMAL/STEM CELL-BASED THERAPY
    Choi, Y.
    Shin, E.
    Lee, K.
    Shin, H.
    Yu, H.
    Lee, J.
    CYTOTHERAPY, 2022, 24 (05) : S49 - S49
  • [10] CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy
    Salas-Mckee, January
    Kong, Weimin
    Gladney, Whitney L.
    Jadlowsky, Julie K.
    Plesa, Gabriela
    Davis, Megan M.
    Fraietta, Joseph A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (05) : 1126 - 1132
12345